Healthcare Sector — activité des initiés

Suivez les achats et ventes d’initiés sur les actions de Healthcare. Découvrez quels dirigeants achètent, l’activité nette des initiés et le pourcentage du flottant échangé parmi 3,435 sociétés.
Les informations fournies dans ce classement sont à titre informatif uniquement et ne constituent pas un conseil financier. Nous ne recommandons aucun investissement spécifique basé sur ces critères.
Entreprises
Données
Abonnez-vous pour accéder à l'ensemble des données
Entreprise Secteur d'activité Cap. boursière ($) # acheteurs nets Valeur nette achetée ($) % du flottant acheté % d'actions détenues par les initiés
Healthcare Services Mid (3.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (3.6bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (3.6bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Mid (3.5bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (3.5bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Mid (3.5bn) 0 Aucune activité — 0–15%
IT Amplifon SpA (AMP)
Healthcare Services Mid (3.5bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Mid (3.5bn) -1–5 -< $100K -0–15% 0–15%
IN Dr. Lal PathLabs Ltd (LALPATHLAB)
Healthcare Services Mid (3.4bn) -6–10 -$100K–$1M -0–15% 50%+
Healthcare Services Mid (3.4bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (3.4bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Mid (3.4bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Mid (3.3bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (3.3bn) 1–5 $1M–$10M 0–15% 0–15%
US Amedisys Inc (AMED)
Healthcare Services Mid (3.3bn) 0 Aucune activité — 0–15%
US Celcuity Inc (CELC)
Pharmaceuticals & Medical Research Mid (3.3bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (3.2bn) 0 Aucune activité — 0–15%
FR Virbac SA (VIRP)
Pharmaceuticals & Medical Research Mid (3.2bn) 0 Aucune activité — 50%+
SE BioArctic AB (BIOA-B)
Pharmaceuticals & Medical Research Mid (3.2bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Mid (3.2bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Mid (3.2bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Mid (3.2bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Mid (3.2bn) -1–5 -$100M+ -50%+ 50%+
Pharmaceuticals & Medical Research Mid (3.1bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (3.1bn) 0 Aucune activité — —
US AtriCure Inc (ATRC)
Healthcare Services Mid (3.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Mid (3.1bn) 0 Aucune activité — 50%+
Healthcare Services Mid (3.1bn) 1–5 $100K–$1M 0–15% 50%+
Pharmaceuticals & Medical Research Mid (3.0bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Mid (3.0bn) 1–5 < $100K 0–15% 0–15%
Healthcare Services Mid (3.0bn) 0 $100K–$1M 0–15% 50%+
Healthcare Services Mid (3.0bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (3.0bn) 0 Aucune activité — 0–15%
DE MorphoSys AG (MOR)
Pharmaceuticals & Medical Research Mid (3.0bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Mid (3.0bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (2.9bn) 1–5 $100K–$1M 0–15% 15–50%
Pharmaceuticals & Medical Research Mid (2.9bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (2.9bn) -1–5 -< $100K -0–15% 0–15%
US Covetrus Inc (CVET)
Healthcare Services Mid (2.9bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.9bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.9bn) 0 Aucune activité — 50%+
ES Almirall SA (ALM)
Pharmaceuticals & Medical Research Mid (2.9bn) 0 Aucune activité — 50%+
Healthcare Services Mid (2.9bn) 0 Aucune activité — 0–15%
US Precigen Inc (PGEN)
Pharmaceuticals & Medical Research Mid (2.9bn) 0 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.9bn) 0 Aucune activité — 15–50%
SE Cellink AB (CLNK-B)
Healthcare Services Mid (2.9bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Mid (2.9bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mid (2.8bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.8bn) 0 Aucune activité — 0–15%
IN Laurus Labs Ltd (LAURUSLABS)
Pharmaceuticals & Medical Research Mid (2.8bn) 0 Aucune activité — 15–50%
Healthcare Services Mid (2.8bn) 0 Aucune activité — 0–15%
US Vericel Corp (VCEL)
Pharmaceuticals & Medical Research Mid (2.8bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.8bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (2.8bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.8bn) 0 Aucune activité — 0–15%
KR L&C Bio Co Ltd (290650)
Healthcare Services Mid (2.8bn) -1–5 -$10M–$100M -0–15% 15–50%
Pharmaceuticals & Medical Research Mid (2.8bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.7bn) 0 Aucune activité — —
Pharmaceuticals & Medical Research Mid (2.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.7bn) 0 Aucune activité — 0–15%
US Neogen Corp (NEOG)
Healthcare Services Mid (2.7bn) 0 -$100K–$1M -0–15% 0–15%
US Xencor Inc (XNCR)
Pharmaceuticals & Medical Research Mid (2.7bn) 0 Aucune activité — 0–15%
US Zai Lab Ltd (9688)
Pharmaceuticals & Medical Research Mid (2.7bn) 0 Aucune activité — 0–15%
US Progyny Inc (PGNY)
Healthcare Services Mid (2.6bn) -1–5 -$1M–$10M -0–15% 0–15%
DE Synlab AG (SYAB)
Healthcare Services Mid (2.6bn) 0 Aucune activité — —
Pharmaceuticals & Medical Research Mid (2.6bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Mid (2.6bn) -1–5 -$100K–$1M -0–15% 15–50%
US AxoGen, Inc. (AXGN)
Healthcare Services Mid (2.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.6bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (2.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.6bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.5bn) 0 Aucune activité — 15–50%
Healthcare Services Mid (2.5bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.5bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Mid (2.5bn) -1–5 -< $100K -0–15% 0–15%
Healthcare Services Mid (2.5bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.5bn) -1–5 -$100K–$1M -0–15% 0–15%
FR Nanobiotix SA (NANO)
Pharmaceuticals & Medical Research Mid (2.5bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Mid (2.5bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (2.5bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.5bn) 0 Aucune activité — 0–15%
IN Pfizer Ltd (PFIZER)
Pharmaceuticals & Medical Research Mid (2.5bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Mid (2.4bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mid (2.4bn) 0 Aucune activité — 15–50%
Healthcare Services Mid (2.4bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.4bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.4bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (2.4bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (2.4bn) -1–5 -$10M–$100M -0–15% 15–50%
Healthcare Services Mid (2.4bn) -6–10 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.4bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.4bn) 0 Aucune activité — 0–15%
DK Ambu A/S (AMBU-B)
Healthcare Services Mid (2.4bn) 0 Aucune activité — 15–50%
IN Granules India Ltd (GRANULES)
Pharmaceuticals & Medical Research Mid (2.3bn) 0 Aucune activité — 15–50%
US Premier Inc (PINC)
Healthcare Services Mid (2.3bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (2.3bn) 1–5 $100K–$1M 0–15% 0–15%
Healthcare Services Mid (2.3bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.3bn) -1–5 -$100K–$1M -0–15% 0–15%
IN Poly Medicure Ltd (POLYMED)
Healthcare Services Mid (2.3bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Mid (2.3bn) -1–5 -$100K–$1M -0–15% 0–15%